Davis Polk advised Sirio Pharma Co. Ltd. on the deal. Sirio Pharma announced the acquisition of a majority stake of Best Formulations, as part of its strategy to...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here